Paul T. Francis-rekin lankidetzan egindako argitalpenak (15)

2018

  1. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

2017

  1. Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status

    CNS Drugs, Vol. 31, Núm. 1, pp. 19-32

2014

  1. Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with Aβ burden

    Neurochemistry International, Vol. 64, Núm. 1, pp. 29-36

  2. Serotonergic therapies for cognitive symptoms in alzheimer's disease: Rationale and current status

    Drugs, Vol. 74, Núm. 7, pp. 729-736

2013

  1. CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients

    Neurobiology of Aging, Vol. 34, Núm. 3, pp. 805-808

2010

  1. Altered NCAM expression associated with the cholinergic system in alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 20, Núm. 2, pp. 659-668

  2. Neurochemical basis for symptomatic treatment of Alzheimer's disease

    Neuropharmacology, Vol. 59, Núm. 4-5, pp. 221-229

2008

  1. Involvement of an altered 5-HT6 receptor function in behavioral symptoms of Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 14, Núm. 1, pp. 43-50

2006

  1. Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease

    Neurobiology of Aging, Vol. 27, Núm. 8, pp. 1110-1117

  2. Selective effects of the APOE ε4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease

    Neurobiology of Disease, Vol. 22, Núm. 3, pp. 555-561

2005

  1. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease

    Neuropsychologia, Vol. 43, Núm. 3, pp. 442-449

2004

  1. Changes in hippocampal SNAP-25 expression following afferent lesions

    Brain Research, Vol. 997, Núm. 1, pp. 133-135

  2. Differential Involvement of 5-HT1B/1D and 5-HT6 Receptors in Cognitive and Non-cognitive Symptoms in Alzheimer's Disease

    Neuropsychopharmacology, Vol. 29, Núm. 2, pp. 410-416

2001

  1. Chronic elevation of amyloid precursor protein in the neocortex or hippocampus of marmosets with selective cholinergic lesions

    Journal of Neural Transmission, Vol. 108, Núm. 7, pp. 809-826

  2. Expression of Amyloid precursor protein, tau and presenilin RNAs in rat hippocampus following deafferentation lesions

    Brain Research, Vol. 907, Núm. 1-2, pp. 222-232